Cas:169534-85-4 Protostemotinine manufacturer & supplier

Chemical Name:Protostemotinine

CAS.NO:169534-85-4

Synonyms:(3S,11S,11aS)-3′-Methoxy-4′,9-dimethyl-3-[(2S,4S)-4-methyl-5-oxotetrahydro-2-furanyl]-2,3,5,6,7,8-hexahydro-1H,5’H,10H-spiro[cyclopenta[b]pyrrolo[1,2-a]azepine-11,2′-furan]-5′,10-dione;(3S,11S,11aS)-3′-Methoxy-4′,9-dimethyl-3-[(2S,4S)-4-methyl-5-oxotetrahydrofuran-2-yl]-2,3,5,6,7,8-hexahydro-1H,5’H,10H-spiro[cyclopenta[b]pyrrolo[1,2-a]azepine-11,2′-furan]-5′,10-dione;Spiro[1H-cyclopenta[b]pyrrolo[1,2-a]azepine-11(10H),2′(5’H)-furan]-5′,10-dione, 2,3,5,6,7,8-hexahydro-3′-methoxy-4′,9-dimethyl-3-[(2S,4S)-tetrahydro-4-methyl-5-oxo-2-furanyl]-, (3S,11S,11aS)-

Molecular Formula:C₂₃H₂₉NO₆

Molecular Weight:415.479

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:690.7±55.0 °C at 760 mmHg

Density:1.3±0.1 g/cm3

Index of Refraction:1.590

PSA:82.14000

Exact Mass:415.199493

LogP:1.86

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like (3S,11S,11aS)-3′-Methoxy-4′,9-dimethyl-3-[(2S,4S)-4-methyl-5-oxotetrahydro-2-furanyl]-2,3,5,6,7,8-hexahydro-1H,5’H,10H-spiro[cyclopenta[b]pyrrolo[1,2-a]azepine-11,2′-furan]-5′,10-dione chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Spiro[1H-cyclopenta[b]pyrrolo[1,2-a]azepine-11(10H),2′(5’H)-furan]-5′,10-dione, 2,3,5,6,7,8-hexahydro-3′-methoxy-4′,9-dimethyl-3-[(2S,4S)-tetrahydro-4-methyl-5-oxo-2-furanyl]-, (3S,11S,11aS)- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(3S,11S,11aS)-3′-Methoxy-4′,9-dimethyl-3-[(2S,4S)-4-methyl-5-oxotetrahydrofuran-2-yl]-2,3,5,6,7,8-hexahydro-1H,5’H,10H-spiro[cyclopenta[b]pyrrolo[1,2-a]azepine-11,2′-furan]-5′,10-dione Use and application,(3S,11S,11aS)-3′-Methoxy-4′,9-dimethyl-3-[(2S,4S)-4-methyl-5-oxotetrahydro-2-furanyl]-2,3,5,6,7,8-hexahydro-1H,5’H,10H-spiro[cyclopenta[b]pyrrolo[1,2-a]azepine-11,2′-furan]-5′,10-dione technical grade,usp/ep/jp grade.

Related News: Rigosertib, Onconova��s lead candidate, is a proprietary Phase 3 small molecule. Protostemotinine manufacturer An analysis of the top 20 global companies by R&D spend for 2018 shows that companies with expensive late-stage pipeline drugs are spending significant proportions of their annual revenue on R&D. Protostemotinine supplier An analysis of the top 20 global companies by R&D spend for 2018 shows that companies with expensive late-stage pipeline drugs are spending significant proportions of their annual revenue on R&D. Protostemotinine vendor Rigosertib, Onconova��s lead candidate, is a proprietary Phase 3 small molecule. Protostemotinine factory Adding Darzalex to Bristol Myers Squibb’s Revlimid and steroid dexamethasone (Rd) could slash the risk of death by 32% in newly diagnosed multiple myeloma patients ineligible to receive stem cell transplants, J&J reported at the European Hematology Association’s virtual congress.